Clinical analysis of 8 patients with breast mucosa-associated lymphoid tissue lymphoma
10.3760/cma.j.cn113855-20190527-00283
- VernacularTitle:乳腺黏膜相关淋巴组织淋巴瘤八例
- Author:
Yuehong ZHU
1
;
Wenjing MENG
;
Jianghua WU
;
Zhongsheng TONG
Author Information
1. 天津医科大学肿瘤医院乳腺内科，国家肿瘤临床医学研究中心，乳腺癌防治教育部重点实验室 天津市"肿瘤防治"重点实验室，天津市恶性肿瘤临床医学研究中心 300060
- From:
Chinese Journal of General Surgery
2020;35(5):371-374
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the clinicopathologic features and prognosis of breast mucosa associated lymphoid tissue(MALT) lymphoma.Methods:Clinical data of 8 breast MALT lymphoma patients were retrospectively analyzed at Tianjin Medical University Cancer Institute and Hospital from Jan 1, 2004 to Jan 31, 2017.Results:All were females, median age was 50 years. Tumors were located in the left breast in 3 cases while 5 cases in the right. All tumors were single in the outer-upper 1/4 quadrant of the breast. By Ann Arbor clinical stageⅠ, Ⅱ, Ⅲ and Ⅳ were 3, 2, 1 and 2, respectively. None of patients had B symptoms. 7 cases underwent surgery.All of the 8 cases received chemotherapy, 6 cases had complete response, one partial response, one with stable in efficacy evaluation. The follow-up time was 2-154 months. The 1, 3, 5-year overall survival rate were 100.0%, 50.0%, 50.0%, median survival time was 144.00 months. The 1-year progress free survival rate was 78.0% and median progress free survival time 28.29 months.Conclusion:Breast MALT is extremely rare without specific clinical features. Almost all are single tumors without B symptom. It′s sensitive to chemotherapy and the patients have fair prognosis.
